High expression of prolyl 4-hydroxylase subunit alpha-2 in lung adenocarcinoma indicates poor prognosis

Xiao-Hong Lu1, Die Sang2, Yu-Rong Zhang2

  • 1Department of Medical Oncology, Beijing Chao yang District San huan Cancer Hospital, Beijing, China; Department of Neurosurgery, Center for Cancer Precision Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Clinics (Sao Paulo, Brazil)
|November 20, 2022
PubMed
Abstract